GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Innovation1 Biotech IVBT · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Innovation1 Biotech — daily IVBT Delayed
Market value
$4,494
Last close × shares
Volume
153
Shares, 30 Oct 2026

About Innovation1 Biotech

Its shares trade under the ticker IVBT. It has been listed since 6 February 2017. In the fiscal year to 31 August 2021, it reported revenue of $3,080 and net income of $1.0m. At that date it held total assets of $181,886 and shareholders' equity of −$224,839.

Innovation1 Biotech, Inc. is a drug discovery company, which engages in the development of modified Schedule 1 molecules of botanical origin to create derivatives for treatment of neurologic, psychiatric, dermatologic, and ophthalmologic disorders. The company is headquartered in Rockaway, New Jersey. The company went IPO on 2017-02-06. The company has a portfolio of products using five preclinical prodrugs, all fully synthetic without connection to botanical sourcing: a mushroom-derived psychedelic molecule for treatment of post-traumatic stress disorder and depression, a cannabinoid and tree bark derived psychedelic for treatment of addiction and three additional cannabinoid prodrugs addressing clinical indications of refractory pediatric epilepsy, hypertrophic scarring, and ocular inflammation. The first agent is a prodrug of psilocin, a molecule naturally found in certain mushroom species. The second agent is a prodrug of synthetic tetrahydrocannobivarin, a molecule naturally found in Cannabis that modulates the two principal cannabinoid receptors: CBR1 and CBR2. The third agent is a prodrug of synthetic cannabidophorol.

Figures and description from our data supplier, not checked against the company's own report.

More about Innovation1 Biotech →

Latest on Innovation1 Biotech

Our reporting

We have not reported on Innovation1 Biotech yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Innovation1 Biotech's ticker?

Innovation1 Biotech trades as IVBT on its US listing, under ISIN US39809D2018.

What was Innovation1 Biotech's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.